To Establish Role of P63 in Evaluating Prostatic Proliferative Lesions

Main Article Content

Dr. Shruti B Bajaj, Dr. Sunita Vagha, Dr. Samarth Shukla

Abstract

Background - Prostatic cancer is second most frequent cancer in world and is the sixth  leading cause of mortality in men   due to malignancies. Histopathological diagnosis of various prostatic proliferative lesions  may pose problems due to presence of mimickers. Hence, p63 is used as an immunochemical marker. P63 is a nuclear protein. It is confined to basal cells/myoepithelial cells of prostate gland.

Article Details

How to Cite
Dr. Shruti B Bajaj, Dr. Sunita Vagha, Dr. Samarth Shukla. (2021). To Establish Role of P63 in Evaluating Prostatic Proliferative Lesions. Annals of the Romanian Society for Cell Biology, 4155 - 4160. Retrieved from http://annalsofrscb.ro/index.php/journal/article/view/534
Section
Articles